Screening of GBA Mutations in Nigerian Patients with Parkinson's Disease

Mov Disord. 2021 Dec;36(12):2971-2973. doi: 10.1002/mds.28803. Epub 2021 Sep 29.

Authors

Affiliations

¹ Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
² Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
³ Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland.
⁴ Department of Clinical Genomics, Mayo Clinic, Jacksonville, Florida, USA.
⁵ Division of Neurology, Lagos State University Teaching Hospital, Lagos, Nigeria.

^# Contributed equally.

PMID: 34586679
DOI: 10.1002/mds.28803

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Genetic Testing
Glucosylceramidase* / genetics
Humans
Mutation / genetics
Nigeria
Parkinson Disease* / genetics

Substances

GBA protein, human
Glucosylceramidase